About ALK-Abelló
As a competent partner of allergy specialists in Germany, ALK develops and distributes allergen therapeutics for the causal treatment of
- Allergic rhinitis and conjunctivitis
- Allergic bronchial asthma and
- Allergic reactions to bee and wasp stings.
In addition to subcutaneous dosage forms, sublingual preparations are available. In November 2006, ALK also became the first company worldwide to introduce causal tablet immunotherapy for grass pollen allergy. The product range also includes allergy diagnostics for prick testing, intradermal testing and nasal and bronchial provocation.
Note: This article has been translated using a computer system without human intervention. LUMITOS offers these automatic translations to present a wider range of company presentation. Since this article has been translated with automatic translation, it is possible that it contains errors in vocabulary, syntax or grammar. The original article in German can be found here.
- Focus : Manufacturer
- Industry : Pharma
